Hallmarks of cancer progression in Barrett's oesophagus

Carmela P. Morales, Rhonda F. Souza, Stuart J. Spechler

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

Context Hanahan and Weinberg proposed in 200 that carcinogenesis involves DNA changes that enable cells to provide their own growth signals, ignore growth-inhibitory signals, avoid apoptosis, replicate without limit, sustain angiogenesis, and invade and proliferate in unnatural locations. The metaplastic cells of Barrett's oesophagus are predisposed to develop these cancer hallmarks. Starting point The genetic changes that have been described in Barrett's oesophagus can be categorised according to the predominant cancer hallmark affected. For example, M Auvinen and colleagues recently observed abnormalities in the expression of vascular endothelial growth factors (VEGFs) in Barrett's oesophagus (J Clin Oncol 2002; 20: 2971-79). These abnormalities can be categorised as those that affect angiogenesis, a process that is essential for the development and progression of tumours. Where next? The cancer hallmarks of Barrett's oesophagus provide a framework to categorise the genetic abnormalities described and to further understanding of the genetic events that underlie oesophageal carcinogenesis.

Original languageEnglish (US)
Pages (from-to)1587-1589
Number of pages3
JournalLancet
Volume360
Issue number9345
DOIs
StatePublished - Nov 16 2002

Fingerprint

Barrett Esophagus
Neoplasms
Carcinogenesis
Vascular Endothelial Growth Factors
Growth
Apoptosis
DNA

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hallmarks of cancer progression in Barrett's oesophagus. / Morales, Carmela P.; Souza, Rhonda F.; Spechler, Stuart J.

In: Lancet, Vol. 360, No. 9345, 16.11.2002, p. 1587-1589.

Research output: Contribution to journalArticle

Morales, Carmela P. ; Souza, Rhonda F. ; Spechler, Stuart J. / Hallmarks of cancer progression in Barrett's oesophagus. In: Lancet. 2002 ; Vol. 360, No. 9345. pp. 1587-1589.
@article{3b6a80733a8c40f0bac7bf9307ca69d6,
title = "Hallmarks of cancer progression in Barrett's oesophagus",
abstract = "Context Hanahan and Weinberg proposed in 200 that carcinogenesis involves DNA changes that enable cells to provide their own growth signals, ignore growth-inhibitory signals, avoid apoptosis, replicate without limit, sustain angiogenesis, and invade and proliferate in unnatural locations. The metaplastic cells of Barrett's oesophagus are predisposed to develop these cancer hallmarks. Starting point The genetic changes that have been described in Barrett's oesophagus can be categorised according to the predominant cancer hallmark affected. For example, M Auvinen and colleagues recently observed abnormalities in the expression of vascular endothelial growth factors (VEGFs) in Barrett's oesophagus (J Clin Oncol 2002; 20: 2971-79). These abnormalities can be categorised as those that affect angiogenesis, a process that is essential for the development and progression of tumours. Where next? The cancer hallmarks of Barrett's oesophagus provide a framework to categorise the genetic abnormalities described and to further understanding of the genetic events that underlie oesophageal carcinogenesis.",
author = "Morales, {Carmela P.} and Souza, {Rhonda F.} and Spechler, {Stuart J.}",
year = "2002",
month = "11",
day = "16",
doi = "10.1016/S0140-6736(02)11569-8",
language = "English (US)",
volume = "360",
pages = "1587--1589",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9345",

}

TY - JOUR

T1 - Hallmarks of cancer progression in Barrett's oesophagus

AU - Morales, Carmela P.

AU - Souza, Rhonda F.

AU - Spechler, Stuart J.

PY - 2002/11/16

Y1 - 2002/11/16

N2 - Context Hanahan and Weinberg proposed in 200 that carcinogenesis involves DNA changes that enable cells to provide their own growth signals, ignore growth-inhibitory signals, avoid apoptosis, replicate without limit, sustain angiogenesis, and invade and proliferate in unnatural locations. The metaplastic cells of Barrett's oesophagus are predisposed to develop these cancer hallmarks. Starting point The genetic changes that have been described in Barrett's oesophagus can be categorised according to the predominant cancer hallmark affected. For example, M Auvinen and colleagues recently observed abnormalities in the expression of vascular endothelial growth factors (VEGFs) in Barrett's oesophagus (J Clin Oncol 2002; 20: 2971-79). These abnormalities can be categorised as those that affect angiogenesis, a process that is essential for the development and progression of tumours. Where next? The cancer hallmarks of Barrett's oesophagus provide a framework to categorise the genetic abnormalities described and to further understanding of the genetic events that underlie oesophageal carcinogenesis.

AB - Context Hanahan and Weinberg proposed in 200 that carcinogenesis involves DNA changes that enable cells to provide their own growth signals, ignore growth-inhibitory signals, avoid apoptosis, replicate without limit, sustain angiogenesis, and invade and proliferate in unnatural locations. The metaplastic cells of Barrett's oesophagus are predisposed to develop these cancer hallmarks. Starting point The genetic changes that have been described in Barrett's oesophagus can be categorised according to the predominant cancer hallmark affected. For example, M Auvinen and colleagues recently observed abnormalities in the expression of vascular endothelial growth factors (VEGFs) in Barrett's oesophagus (J Clin Oncol 2002; 20: 2971-79). These abnormalities can be categorised as those that affect angiogenesis, a process that is essential for the development and progression of tumours. Where next? The cancer hallmarks of Barrett's oesophagus provide a framework to categorise the genetic abnormalities described and to further understanding of the genetic events that underlie oesophageal carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0037121243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037121243&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(02)11569-8

DO - 10.1016/S0140-6736(02)11569-8

M3 - Article

C2 - 12443613

AN - SCOPUS:0037121243

VL - 360

SP - 1587

EP - 1589

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9345

ER -